FDA Adverse Event Injury Summary report: N

NEUROSTAR ADVANCED THERAPY

MDR report key: 16035931 · Received December 22, 2022

Report

Report Number
3004824012-2022-00025
Event Type
Injury
Date Received
December 22, 2022
Date of Event
November 17, 2022
Report Date
December 22, 2022
Manufacturer
NEURONETICS, INC.
Product Code
OBP
UDI-DI
00850005944522
PMA / PMN Number
K201158
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION INCLUDED A REVIEW OF THE PATIENT'S MEDICAL HISTORY AND CONCOMITANT MEDICATIONS. THE PATIENT WAS DIAGNOSED WITH ASPERGER'S SYNDROME WHICH MAY HAVE LOWERED HIS SEIZURE THRESHOLD. SEIZURE DISORDERS AND EPILEPSY ARE FREQUENTLY REPORTED COMORBIDITIES IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER WHICH INCLUDES THE SIGNS AND SYMPTOMS THAT WERE ONCE PART OF AN ASPERGER'S DIAGNOSIS. ADDITIONALLY, TWO OF THE MEDICATIONS THE PATIENT WAS TAKING (CLOMID AND AMPHETAMINE-DEXTROAMPHETAMINE) COULD ALSO POTENTIALLY LOWER HIS SEIZURE THRESHOLD.

Description of Event or Problem · 0

NEURONETICS, INC. RECEIVED A CALL FROM A COMPANY REPRESENTATIVE THAT ONE OF HIS ACCOUNTS HAD A PATIENT WHO HAD A SEIZURE DURING HIS 10TH TMS TREATMENT SESSION. THE SEIZURE LASTED ONLY 2-3 MINUTES BUT THE PATIENT WAS TAKEN TO THE EMERGENCY ROOM AND HAD A CT SCAN WHICH WAS NORMAL. THE PATIENT WAS DISCHARGED THE SAME DAY AND HAS BEEN DOING WELL WITH NO VISIBLE LASTING ISSUES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2917121 NEUROSTAR ADVANCED THERAPY TRANSCRANIAL MAGNETIC STIMULATOR OBP NEURONETICS, INC. NS 3.7 00850005944522

Patients

Seq Age Sex Outcome Treatment
1 32 YR Male Other AMPHETAMINE-DEXTROAMPHETAMINE 10MG BID (HOLDING)| ANASTROZOLE 1MG| ARMOUR THYROID 90MG IN AM| CLOMID 50MG 1/2 TABLET ONCE WEEKLY| LISINOPRIL 40MG| VERAPAMIL 40MG